Prestige Consumer Healthcare Price to Free Cash Flow Ratio 2012-2025 | PBH
Historical price to free cash flow ratio values for Prestige Consumer Healthcare (PBH) since 2012.
| Prestige Consumer Healthcare Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-02-17 | 66.27 | 12.89 | |
| 2025-09-30 | 62.40 | $5.14 | 12.14 |
| 2025-06-30 | 79.85 | $5.36 | 14.90 |
| 2025-03-31 | 85.97 | $4.86 | 17.70 |
| 2024-12-31 | 78.09 | $4.97 | 15.72 |
| 2024-09-30 | 72.10 | $5.08 | 14.20 |
| 2024-06-30 | 68.85 | $4.91 | 14.03 |
| 2024-03-31 | 72.56 | $4.77 | 15.21 |
| 2023-12-31 | 61.22 | $4.65 | 13.15 |
| 2023-09-30 | 57.19 | $4.33 | 13.20 |
| 2023-06-30 | 59.43 | $4.25 | 13.98 |
| 2023-03-31 | 62.63 | $4.45 | 14.08 |
| 2022-12-31 | 62.60 | $4.48 | 13.96 |
| 2022-09-30 | 49.83 | $4.67 | 10.66 |
| 2022-06-30 | 58.80 | $4.71 | 12.48 |
| 2022-03-31 | 52.94 | $4.92 | 10.75 |
| 2021-12-31 | 60.65 | $4.80 | 12.62 |
| 2021-09-30 | 56.11 | $4.42 | 12.70 |
| 2021-06-30 | 52.10 | $4.13 | 12.63 |
| 2021-03-31 | 44.08 | $4.22 | 10.45 |
| 2020-12-31 | 34.87 | $4.12 | 8.46 |
| 2020-09-30 | 36.42 | $4.33 | 8.41 |
| 2020-06-30 | 37.56 | $4.41 | 8.51 |
| 2020-03-31 | 36.68 | $3.96 | 9.26 |
| 2019-12-31 | 40.50 | $3.91 | 10.36 |
| 2019-09-30 | 34.69 | $3.62 | 9.58 |
| 2019-06-30 | 31.68 | $3.40 | 9.31 |
| 2019-03-31 | 29.91 | $3.43 | 8.71 |
| 2018-12-31 | 30.88 | $3.48 | 8.88 |
| 2018-09-30 | 37.89 | $3.48 | 10.89 |
| 2018-06-30 | 37.90 | $3.74 | 10.15 |
| 2018-03-31 | 33.30 | $3.69 | 9.02 |
| 2017-12-31 | 43.86 | $2.85 | 15.40 |
| 2017-09-30 | 49.47 | $2.80 | 17.67 |
| 2017-06-30 | 52.15 | $2.74 | 19.02 |
| 2017-03-31 | 54.87 | $2.73 | 20.08 |
| 2016-12-31 | 51.45 | $3.34 | 15.38 |
| 2016-09-30 | 47.67 | $3.45 | 13.83 |
| 2016-06-30 | 54.71 | $3.40 | 16.11 |
| 2016-03-31 | 52.72 | $3.26 | 16.19 |
| 2015-12-31 | 50.84 | $3.47 | 14.65 |
| 2015-09-30 | 44.60 | $3.66 | 12.18 |
| 2015-06-30 | 45.66 | $3.30 | 13.84 |
| 2015-03-31 | 42.36 | $3.04 | 13.93 |
| 2014-12-31 | 34.29 | $2.68 | 12.78 |
| 2014-09-30 | 31.97 | $2.12 | 15.10 |
| 2014-06-30 | 33.47 | $2.22 | 15.06 |
| 2014-03-31 | 26.91 | $2.08 | 12.95 |
| 2013-12-31 | 35.35 | $2.18 | 16.20 |
| 2013-09-30 | 29.49 | $2.42 | 12.18 |
| 2013-06-30 | 28.53 | $2.62 | 10.88 |
| 2013-03-31 | 25.15 | $2.48 | 10.16 |
| 2012-12-31 | 19.61 | $2.16 | 9.07 |
| 2012-09-30 | 16.60 | $1.74 | 9.55 |
| 2012-06-30 | 15.48 | $1.28 | 12.10 |
| 2012-03-31 | 17.11 | $1.32 | 12.99 |
| 2011-12-31 | 11.03 | $1.44 | 7.68 |
| 2011-09-30 | 8.86 | $1.51 | 5.85 |
| 2011-06-30 | 12.57 | $1.60 | 7.85 |
| 2011-03-31 | 11.26 | $1.71 | 6.59 |
| 2010-12-31 | 11.70 | $1.39 | 8.45 |
| 2010-09-30 | 9.68 | $1.23 | 7.87 |
| 2010-06-30 | 6.93 | $1.23 | 5.66 |
| 2010-03-31 | 8.81 | $1.17 | 7.51 |
| 2009-12-31 | 7.69 | $1.27 | 6.07 |
| 2009-09-30 | 6.89 | $1.39 | 4.97 |
| 2009-06-30 | 6.02 | $1.38 | 4.37 |
| 2009-03-31 | 5.07 | $1.33 | 3.83 |
| 2008-12-31 | 10.33 | $1.25 | 8.27 |
| 2008-09-30 | 8.69 | $1.19 | 7.28 |
| 2008-06-30 | 10.44 | $1.03 | 10.14 |
| 2008-03-31 | 8.01 | $0.89 | 9.00 |
| 2007-12-31 | 7.32 | $1.03 | 7.12 |
| 2007-09-30 | 10.75 | $1.00 | 10.71 |
| 2007-06-30 | 12.71 | $1.17 | 10.87 |
| 2007-03-31 | 11.60 | $1.43 | 8.13 |
| 2006-12-31 | 12.75 | $2.16 | 5.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.160B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |